Recombinant HTLV-III proteins and uses thereof
US5142025A · kind A · utility
8Cited by
7References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 24, 1990 |
| Grant date | Aug 25, 1992 |
| Priority date | — |
| Expiry date | Sep 24, 2010 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/221
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel recombinant HTLV-III fusion proteins denoted R10, PB1, 590, KH1, and the HIV portion of each of these proteins are useful in the diagnosis, prophylaxis or therapy of AIDS. Protein R10 is a 95 kD fusion protein; protein PB1 is a 26 kD fusion protein; protein 590 is an 86 kD fusion protein; and protein KH1 is a 70 kD fusion protein. These proteins are considered to be especially useful to prepare vaccines for the HTLV-III virus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.